Overview

Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
Dose-response in Japanese patients with postmenopausal osteoporosis.
Phase:
Phase 2
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Bazedoxifene